The Warburg Way® uses insulin to deprive cancer cells of the levels of blood glucose they need to survive. This palliative cancer treatment is named in honor of Otto Warburg, a Nobel Laureate. Today, the "Warburg Effect" is not only recognized as a "hallmark of cancer treatment" but has also served as the scientific basis for cancer detection using fluorodeoxyglucose (FDG) positron emission tomography (PET) scans. In 1927, Warburg suggested that treating cancer patients with insulin can deprive glucose to the cancer cells by lowering the blood glucose levels and may inhibit tumor growth. The Warburg Way® (TWW) integrates the effect with patented and proprietary science.
TWW seeks to respond to the well-documented pain reduction effect on the quality of life and the financial stress of a cancer diagnosis. Pain reduction, improved quality of life, and low-cost delivery have been demonstrated. To date, most treatments have been used with patients with advanced stages of disease, people who have limited options and who have previously experienced other standard treatments without success. TWW® is applicable for all stages of cancer, from diagnosis through treatment to recovery.
